Author: AdminBit

Aug. 7, 2026 /PRNewswire/ — Atossa Therapeutics, Inc. (Nasdaq: ATOS) (Atossa or the Company), a clinical-stage biopharmaceutical company developing novel therapies in oncology and other areas of high unmet clinical need, today announced its financial results and provided an update on recent corporate developments for the second quarter ended June 30, 2026

Read More

LAS VEGAS — April 20, 2026 — Today, at Adobe Summit—the flagship customer experience conference—Adobe (Nasdaq:ADBE)—the global technology leader that unleashes creativity, productivity and customer experiences through innovative tools and platforms—announced major updates across Adobe GenStudio to deliver an agentic content supply chain that connects enterprise context, brand intelligence and AI agents across planning, creation,…

Read More